Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Metformin - new data for an "old", but efficient, safe and reliable antidiabetic drug].

Orvosi hetilap - 5 Jun 2016

Winkler Gábor

Abstract excerpt

Metformin is the basic drug of antihyperglycemic therapy in type 2 diabetes: according to actual therapeutic guidelines, it should be given in the absence of contraindications or intolerance during the whole course of the disease even after the initiation of insulin therapy. Recently more and more details have been explored regarding the molecular background of its effects, however, in parallel with the enormous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AMP-Activated Protein Kinase Kinases
Share to AMP-Activated Protein Kinases
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypoglycemic Agents

Share to Metformin

Share to Polymorphism, Single Nucleotide

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 27233831
DOI: 10.1556/650.2016.30485

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Metformin - new data for an "old", but efficient, safe and reliable antidiabetic drug].PMID 27233831Read ↗

Is Metformin a Perfect Drug? Updates in Pharmacokinetics and Pharmacodynamics.Semantic proximity Read ↗

Metformin: an old drug with potential therapeutic function in antitumorSemantic proximity Read ↗

A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 DiabetesSemantic proximity Read ↗

An Update on the Pharmacogenomics of Metformin: Progress, Problems and PotentialSemantic proximity Read ↗

Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.Semantic proximity Read ↗

Molecular mechanism of action of metformin: old or new insights?Semantic proximity Read ↗

Function and therapeutic potential of metformin in multiple diseasesSemantic proximity Read ↗

Anti-tumor activity of metformin: from metabolic and epigenetic perspectivesSemantic proximity Read ↗

Current understanding of the pharmacogenomics of metformin.Semantic proximity Read ↗

Exploring the Next Generation of Metformin Derivatives and Their Biomedical PromiseSemantic proximity Read ↗

Metformin pathwaysSemantic proximity Read ↗

Metformin Pharmacogenomics: Current Status and Future DirectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.